Literature DB >> 26137955

Cerebral Microbleeds Are Associated With an Increased Risk of Stroke: The Rotterdam Study.

Saloua Akoudad1, Marileen L P Portegies1, Peter J Koudstaal1, Albert Hofman1, Aad van der Lugt1, M Arfan Ikram2, Meike W Vernooij1.   

Abstract

BACKGROUND: Cerebral microbleeds are highly prevalent in people with clinically manifest cerebrovascular disease and have been shown to increase the risk of stroke recurrence. Microbleeds are also frequently found in healthy elderly, a population in which the clinical implication of microbleeds is unknown. METHODS AND
RESULTS: In the population-based Rotterdam Study, the presence, number, and location of microbleeds were assessed at baseline on brain MRI of 4759 participants aged ≥45 years. Participants were followed for incident stroke throughout the study period (2005-2013). We used Cox proportional hazards to investigate if people with microbleeds were at increased risk of stroke in comparison with those without microbleeds, adjusting for demographic, genetic, and cardiovascular risk, and cerebrovascular imaging markers. Microbleed prevalence was 18.7% (median count 1 [1-111]). During mean follow-up of 4.9 years (standard deviation, 1.6) 93 strokes occurred (72 ischemic, 11 hemorrhagic, and 10 unspecified). Microbleed presence was associated with an increased risk of all strokes (hazard ratio, 1.93; 95% confidence interval, 1.25-2.99). The risk increased with greater microbleed count. In comparison with those without microbleeds, participants with microbleeds in locations suggestive of cerebral amyloid angiopathy (lobar with or without cerebellar microbleeds) were at increased risk of intracerebral hemorrhage (hazard ratio, 5.27; 95% confidence interval, 1.38-20.23). Microbleeds at other locations were associated with an increased risk of both ischemic stroke and intracerebral hemorrhage.
CONCLUSIONS: Microbleeds on MRI are associated with an increased risk of stroke in the general population. Our results strengthen the notion that microbleeds mark progression of cerebrovascular pathology and represent a precursor of stroke.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cerebral microbleeds; epidemiology; hemorrhage; magnetic resonance imaging; stroke

Mesh:

Year:  2015        PMID: 26137955     DOI: 10.1161/CIRCULATIONAHA.115.016261

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  67 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

Review 2.  Brain health and shared risk factors for dementia and stroke.

Authors:  Hannah Gardener; Clinton B Wright; Tatjana Rundek; Ralph L Sacco
Journal:  Nat Rev Neurol       Date:  2015-10-20       Impact factor: 42.937

3.  ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly.

Authors:  Stephanie A Ward; Parnesh Raniga; Nicholas J Ferris; Robyn L Woods; Elsdon Storey; Michael J Bailey; Amy Brodtmann; Paul A Yates; Geoffrey A Donnan; Ruth E Trevaks; Rory Wolfe; Gary F Egan; John J McNeil
Journal:  Int J Stroke       Date:  2016-09-24       Impact factor: 5.266

Review 4.  Cerebral small vessel disease: neuroimaging markers and clinical implication.

Authors:  Xiaodong Chen; Jihui Wang; Yilong Shan; Wei Cai; Sanxin Liu; Mengyan Hu; Siyuan Liao; Xuehong Huang; Bingjun Zhang; Yuge Wang; Zhengqi Lu
Journal:  J Neurol       Date:  2018-10-05       Impact factor: 4.849

5.  Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population.

Authors:  Sara Shams; Juha Martola; Andreas Charidimou; Lena Cavallin; Tobias Granberg; Mana Shams; Yngve Forslin; Peter Aspelin; Maria Kristoffersen-Wiberg; Lars-Olof Wahlund
Journal:  Neurology       Date:  2016-08-17       Impact factor: 9.910

6.  Cerebral microbleeds topography and cerebrospinal fluid biomarkers in cognitive impairment.

Authors:  Sara Shams; Tobias Granberg; Juha Martola; Andreas Charidimou; Xiaozhen Li; Mana Shams; Seyed-Mohammad Fereshtehnejad; Lena Cavallin; Peter Aspelin; Maria Wiberg-Kristoffersen; Lars-Olof Wahlund
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

Review 7.  Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.

Authors:  M Edip Gurol
Journal:  Stroke       Date:  2017-12-04       Impact factor: 7.914

8.  Genome-Wide Association Study of Cerebral Microbleeds on MRI.

Authors:  Hong-Qi Li; Wen-Jie Cai; Xiao-He Hou; Mei Cui; Lan Tan; Jin-Tai Yu; Qiang Dong
Journal:  Neurotox Res       Date:  2019-06-18       Impact factor: 3.911

9.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

Review 10.  Vascular Cognitive Impairment.

Authors:  Jonathan Graff-Radford
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.